Agilent Technologies Inc. has unveiled the Mito-rOCR Assay Kit, an accessible tool for contract labs specializing in mitochondrial analysis research. This assay kit enables labs to accurately measure relative mitochondrial respiration, or rOCR, a critical indicator of cellular health. Designed to work with leading plate readers like the BioTek Cytation series, the Mito-rOCR Assay Kit simplifies and enhances the study of mitochondrial dysfunction, an area relevant to disease, drug screening, and toxicology studies.
Mitochondrial function is integral to energy production and cellular activity, making this assay essential for understanding disease pathways, cellular responses, and pharmacodynamics.
Key Advantages of the Agilent Mito-rOCR Assay Kit for Contract Testing Labs
- Flexible Platform Compatibility: Compatible with various readers, including BioTek Cytation
- Non-Invasive Assay Design: Reagents remain outside cells, preserving cellular integrity
- Streamlined Protocol: Reduces complexity, allowing efficient setup and analysis
- Cloud-Based Data Analysis: Integrates with Agilent Seahorse Analytics for easy visualization
- Enhanced Sensitivity: Detects changes in mitochondrial function with high accuracy
Precision and Efficiency in Mitochondrial Analysis for Research Labs
By offering a non-invasive and reversible design, the Mito-rOCR Assay Kit enables contract labs to conduct follow-up analyses without cellular interference. With Agilent Seahorse Analytics, labs can accelerate data processing, making the kit ideal for labs seeking high-throughput, efficient mitochondrial analysis. The Mito-rOCR Assay Kit extends Agilent’s commitment to innovative metabolic analysis solutions, providing tools that meet the high standards of contract research labs.
This article is an AI generated summary of a published press release: “Agilent Announces the Innovative Mito-rOCR Assay Kit for Mitochondrial Research“
